Aerovate Therapeutics Ownership 2024 | Who Owns Aerovate Therapeutics Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

97.79%

Insider Ownership

0.02%

Retail Ownership

2.19%

Institutional Holders

93.00

Aerovate Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RA CAPITAL MANAGEMENT, L.P.	33.07%	0.20%	9,192,092	928,110	11.23%	15,258,873	Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.	13.52%	0.32%	3,758,686	-	-	6,239,419	Jun 30, 2024
TCG CROSSOVER MANAGEMENT, LLC	8.06%	0.39%	2,240,809	39,535	1.80%	3,719,743	Jun 30, 2024
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC	6.47%	0.31%	1,799,232	-240,017	-11.77%	2,986,725	Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	5.08%	0.04%	1,411,608	1,411,608	100.00%	2,343,269	Jun 30, 2024
VANGUARD GROUP INC	3.98%	-	1,105,289	433,014	64.41%	1,834,780	Jun 30, 2024
BLACKROCK INC.	3.54%	-	983,063	273,311	38.51%	1,631,884	Jun 30, 2024
ARTAL GROUP S.A.	2.91%	0.03%	809,600	809,600	100.00%	1,343,936	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	2.31%	0.00%	641,947	579,392	926.21%	1,065,632	Jun 30, 2024
BAKER BROS. ADVISORS LP	2.26%	0.01%	628,939	-1,051,578	-62.57%	1,044,039	Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP	1.67%	0.12%	465,440	61,755	15.30%	772,630	Jun 30, 2024
OPALEYE MANAGEMENT INC.	1.58%	0.17%	440,000	440,000	100.00%	730,400	Jun 30, 2024
IKARIAN CAPITAL, LLC	1.32%	0.11%	367,965	-	-	610,822	Jun 30, 2024
STATE STREET CORP	1.23%	-	341,190	111,204	48.35%	566,375,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.14%	-	317,174	35,414	12.57%	526,583	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	1.00%	0.00%	278,816	255,903	1116.85%	462,835	Jun 30, 2024
VERITION FUND MANAGEMENT LLC	0.90%	0.00%	248,952	248,952	100.00%	413,260	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	0.89%	0.08%	246,936	231,036	1453.06%	409,914	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	0.72%	0.04%	200,000	200,000	100.00%	332,000	Jun 30, 2024
SG AMERICAS SECURITIES, LLC	0.65%	0.00%	179,493	179,493	100.00%	298,000	Jun 30, 2024

Aerovate Therapeutics's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 33.07% of the company's total share outstanding, currently valued at $15.26M. The top 10 institutional shareholders own together 81.20% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TCG CROSSOVER MANAGEMENT, LLC	8.06%	0.39%	2,240,809	39,535	1.80%	3,719,743	Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.	13.52%	0.32%	3,758,686	-	-	6,239,419	Jun 30, 2024
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC	6.47%	0.31%	1,799,232	-240,017	-11.77%	2,986,725	Jun 30, 2024
RA CAPITAL MANAGEMENT, L.P.	33.07%	0.20%	9,192,092	928,110	11.23%	15,258,873	Jun 30, 2024
OPALEYE MANAGEMENT INC.	1.58%	0.17%	440,000	440,000	100.00%	730,400	Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP	1.67%	0.12%	465,440	61,755	15.30%	772,630	Jun 30, 2024
FIFTH LANE CAPITAL, LP	0.18%	0.12%	50,000	50,000	100.00%	83,000	Jun 30, 2024
IKARIAN CAPITAL, LLC	1.32%	0.11%	367,965	-	-	610,822	Jun 30, 2024
NAN FUNG GROUP HOLDINGS LTD	0.17%	0.08%	47,936	-	-	79,574	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	0.89%	0.08%	246,936	231,036	1453.06%	409,914	Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	5.08%	0.04%	1,411,608	1,411,608	100.00%	2,343,269	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	0.72%	0.04%	200,000	200,000	100.00%	332,000	Jun 30, 2024
ARTAL GROUP S.A.	2.91%	0.03%	809,600	809,600	100.00%	1,343,936	Jun 30, 2024
	0.05%	0.03%	13,089	13,089	100.00%	22,906	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.00%	0.03%	1,000	1,000	100.00%	166,000	Jun 30, 2024
WARBERG ASSET MANAGEMENT LLC	0.24%	0.02%	67,449	67,449	100.00%	111,291	Jun 30, 2024
VALUES FIRST ADVISORS, INC.	0.06%	0.02%	15,381	15,381	100.00%	25,532	Jun 30, 2024
GSA CAPITAL PARTNERS LLP	0.46%	0.01%	126,632	126,632	100.00%	210,000	Jun 30, 2024
BAKER BROS. ADVISORS LP	2.26%	0.01%	628,939	-1,051,578	-62.57%	1,044,039	Jun 30, 2024
QUARRY LP	0.08%	0.01%	22,500	22,500	100.00%	37,350	Jun 30, 2024

The largest Aerovate Therapeutics shareholder by % of total assets is TCG CROSSOVER MANAGEMENT, LLC. The company owns 2.24M shares of Aerovate Therapeutics (AVTE), representing 0.39% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	5.08%	0.04%	1,411,608	1,411,608	100.00%	2,343,269	Jun 30, 2024
RA CAPITAL MANAGEMENT, L.P.	33.07%	0.20%	9,192,092	928,110	11.23%	15,258,873	Jun 30, 2024
ARTAL GROUP S.A.	2.91%	0.03%	809,600	809,600	100.00%	1,343,936	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	2.31%	0.00%	641,947	579,392	926.21%	1,065,632	Jun 30, 2024
OPALEYE MANAGEMENT INC.	1.58%	0.17%	440,000	440,000	100.00%	730,400	Jun 30, 2024
VANGUARD GROUP INC	3.98%	-	1,105,289	433,014	64.41%	1,834,780	Jun 30, 2024
BLACKROCK INC.	3.54%	-	983,063	273,311	38.51%	1,631,884	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	1.00%	0.00%	278,816	255,903	1116.85%	462,835	Jun 30, 2024
VERITION FUND MANAGEMENT LLC	0.90%	0.00%	248,952	248,952	100.00%	413,260	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	0.89%	0.08%	246,936	231,036	1453.06%	409,914	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	0.72%	0.04%	200,000	200,000	100.00%	332,000	Jun 30, 2024
SG AMERICAS SECURITIES, LLC	0.65%	0.00%	179,493	179,493	100.00%	298,000	Jun 30, 2024
GSA CAPITAL PARTNERS LLP	0.46%	0.01%	126,632	126,632	100.00%	210,000	Jun 30, 2024
STATE STREET CORP	1.23%	-	341,190	111,204	48.35%	566,375,000	Jun 30, 2024
GOLDMAN SACHS GROUP INC	0.33%	-	90,948	90,948	100.00%	150,974	Jun 30, 2024
WARBERG ASSET MANAGEMENT LLC	0.24%	0.02%	67,449	67,449	100.00%	111,291	Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP	1.67%	0.12%	465,440	61,755	15.30%	772,630	Jun 30, 2024
SQUAREPOINT OPS LLC	0.21%	0.00%	57,082	57,082	100.00%	94,756	Jun 30, 2024
ALLIANCEBERNSTEIN L.P.	0.25%	-	69,910	56,810	433.66%	116,051	Jun 30, 2024
FIFTH LANE CAPITAL, LP	0.18%	0.12%	50,000	50,000	100.00%	83,000	Jun 30, 2024

As of Jun 30 2024, Aerovate Therapeutics's largest institutional buyer is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). The company purchased 1.41M stocks of AVTE, valued at $2.34M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.	-	-	-	-1,204,867	-100.00%	-	Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP	-	-	-	-1,069,796	-100.00%	-	Jun 30, 2024
BAKER BROS. ADVISORS LP	2.26%	0.01%	628,939	-1,051,578	-62.57%	1,044,039	Jun 30, 2024
GREAT POINT PARTNERS LLC	-	-	-	-887,690	-100.00%	-	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	-	-	-	-794,992	-100.00%	-	Jun 30, 2024
ORBIMED ADVISORS LLC	-	-	-	-565,374	-100.00%	-	Jun 30, 2024
FMR LLC	0.00%	-	153	-537,377	-99.97%	254	Jun 30, 2024
EVENTIDE ASSET MANAGEMENT, LLC	-	-	-	-445,500	-100.00%	-	Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.	-	-	-	-399,824	-100.00%	-	Jun 30, 2024
ENSIGN PEAK ADVISORS, INC	-	-	-	-262,257	-100.00%	-	Jun 30, 2024
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC	6.47%	0.31%	1,799,232	-240,017	-11.77%	2,986,725	Jun 30, 2024
GHOST TREE CAPITAL, LLC	-	-	-	-225,000	-100.00%	-	Jun 30, 2024
WOODLINE PARTNERS LP	-	-	-	-200,000	-100.00%	-	Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP	-	-	-	-110,264	-100.00%	-	Jun 30, 2024
EXOME ASSET MANAGEMENT LLC	-	-	-	-98,485	-100.00%	-	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	-	-	-	-91,188	-100.00%	-	Jun 30, 2024
WALLEYE CAPITAL LLC	-	-	-	-54,520	-100.00%	-	Jun 30, 2024
EVERSEPT PARTNERS, LP	-	-	-	-54,150	-100.00%	-	Jun 30, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)	-	-	-	-44,320	-100.00%	-	Jun 30, 2024
FRED ALGER MANAGEMENT, LLC	-	-	-	-43,790	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Aerovate Therapeutics's biggest institutional seller is FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The company sold -1.20M shares of AVTE, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	5.08%	0.04%	1,411,608	1,411,608	100.00%	2,343,269	Jun 30, 2024
ARTAL GROUP S.A.	2.91%	0.03%	809,600	809,600	100.00%	1,343,936	Jun 30, 2024
OPALEYE MANAGEMENT INC.	1.58%	0.17%	440,000	440,000	100.00%	730,400	Jun 30, 2024
VERITION FUND MANAGEMENT LLC	0.90%	0.00%	248,952	248,952	100.00%	413,260	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	0.72%	0.04%	200,000	200,000	100.00%	332,000	Jun 30, 2024
SG AMERICAS SECURITIES, LLC	0.65%	0.00%	179,493	179,493	100.00%	298,000	Jun 30, 2024
GSA CAPITAL PARTNERS LLP	0.46%	0.01%	126,632	126,632	100.00%	210,000	Jun 30, 2024
GOLDMAN SACHS GROUP INC	0.33%	-	90,948	90,948	100.00%	150,974	Jun 30, 2024
WARBERG ASSET MANAGEMENT LLC	0.24%	0.02%	67,449	67,449	100.00%	111,291	Jun 30, 2024
SQUAREPOINT OPS LLC	0.21%	0.00%	57,082	57,082	100.00%	94,756	Jun 30, 2024
FIFTH LANE CAPITAL, LP	0.18%	0.12%	50,000	50,000	100.00%	83,000	Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC	0.11%	0.00%	31,894	31,894	100.00%	52,944	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	0.11%	-	30,000	30,000	100.00%	49,800	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.11%	0.00%	29,400	29,400	100.00%	48,804	Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD	0.09%	0.00%	24,900	24,900	100.00%	41,334	Jun 30, 2024
PROSPERA FINANCIAL SERVICES INC	0.09%	0.00%	23,919	23,919	100.00%	39,705	Jun 30, 2024
QUARRY LP	0.08%	0.01%	22,500	22,500	100.00%	37,350	Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP	0.08%	0.00%	21,723	21,723	100.00%	36,000	Jun 30, 2024
XTX TOPCO LTD	0.08%	0.00%	21,143	21,143	100.00%	35,097	Jun 30, 2024
GTS SECURITIES LLC	0.07%	0.00%	20,673	20,673	100.00%	34,317	Jun 30, 2024
CORSAIR CAPITAL MANAGEMENT, L.P.	0.07%	0.01%	20,100	20,100	100.00%	33,366	Jun 30, 2024
VALUES FIRST ADVISORS, INC.	0.06%	0.02%	15,381	15,381	100.00%	25,532	Jun 30, 2024
LMR PARTNERS LLP	0.05%	0.00%	14,100	14,100	100.00%	23,406	Jun 30, 2024
	0.05%	0.03%	13,089	13,089	100.00%	22,906	Jun 30, 2024
ALGERT GLOBAL LLC	0.05%	0.00%	12,715	12,715	100.00%	21,000	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.04%	0.00%	12,500	12,500	100.00%	20,750	Jun 30, 2024
CAPTION MANAGEMENT, LLC	0.03%	0.00%	9,400	9,400	100.00%	15,604	Jun 30, 2024
COREBRIDGE FINANCIAL, INC.	0.03%	0.00%	7,256	7,256	100.00%	12,045	Jun 30, 2024
CAPTION MANAGEMENT, LLC	0.03%	0.00%	7,000	7,000	100.00%	11,620	Jun 30, 2024
SIMPLEX TRADING, LLC	0.02%	-	5,853	5,853	100.00%	9,000	Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.	0.02%	-	4,881	4,881	100.00%	8,102	Jun 30, 2024
VIRTUS ETF ADVISERS LLC	0.01%	0.00%	3,683	3,683	100.00%	6,114	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.01%	-	3,453	3,453	100.00%	5,732	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.01%	-	2,806	2,806	100.00%	4,658,000	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	0.01%	0.00%	2,500	2,500	100.00%	4,150	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.00%	0.03%	1,000	1,000	100.00%	166,000	Jun 30, 2024
SRS CAPITAL ADVISORS, INC.	0.00%	-	117	117	100.00%	195	Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP	0.00%	-	100	100	100.00%	166	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	69	69	100.00%	115	Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.	-	-	11	11	100.00%	18	Jun 30, 2024

Aerovate Therapeutics's largest new institutional shareholder by number of shares is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), purchased 1.41M shares, valued at $2.34M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.	-	-	-	-1,204,867	-100.00%	-	Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP	-	-	-	-1,069,796	-100.00%	-	Jun 30, 2024
GREAT POINT PARTNERS LLC	-	-	-	-887,690	-100.00%	-	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	-	-	-	-794,992	-100.00%	-	Jun 30, 2024
ORBIMED ADVISORS LLC	-	-	-	-565,374	-100.00%	-	Jun 30, 2024
EVENTIDE ASSET MANAGEMENT, LLC	-	-	-	-445,500	-100.00%	-	Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.	-	-	-	-399,824	-100.00%	-	Jun 30, 2024
ENSIGN PEAK ADVISORS, INC	-	-	-	-262,257	-100.00%	-	Jun 30, 2024
GHOST TREE CAPITAL, LLC	-	-	-	-225,000	-100.00%	-	Jun 30, 2024
WOODLINE PARTNERS LP	-	-	-	-200,000	-100.00%	-	Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP	-	-	-	-110,264	-100.00%	-	Jun 30, 2024
EXOME ASSET MANAGEMENT LLC	-	-	-	-98,485	-100.00%	-	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	-	-	-	-91,188	-100.00%	-	Jun 30, 2024
WALLEYE CAPITAL LLC	-	-	-	-54,520	-100.00%	-	Jun 30, 2024
EVERSEPT PARTNERS, LP	-	-	-	-54,150	-100.00%	-	Jun 30, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)	-	-	-	-44,320	-100.00%	-	Jun 30, 2024
FRED ALGER MANAGEMENT, LLC	-	-	-	-43,790	-100.00%	-	Jun 30, 2024
SHAY CAPITAL LLC	-	-	-	-24,588	-100.00%	-	Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC	-	-	-	-20,685	-100.00%	-	Jun 30, 2024
ALPS ADVISORS INC	-	-	-	-19,519	-100.00%	-	Jun 30, 2024
D. E. SHAW & CO., INC.	-	-	-	-17,265	-100.00%	-	Jun 30, 2024
PDT PARTNERS, LLC	-	-	-	-12,680	-100.00%	-	Jun 30, 2024
JUMP FINANCIAL, LLC	-	-	-	-9,600	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-7,500	-100.00%	-	Jun 30, 2024
AMERICAN CENTURY COMPANIES INC	-	-	-	-7,124	-100.00%	-	Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.	-	-	-	-5,509	-100.00%	-	Jun 30, 2024
METLIFE INVESTMENT MANAGEMENT, LLC	-	-	-	-5,228	-100.00%	-	Jun 30, 2024
ENTRYPOINT CAPITAL, LLC	-	-	-	-3,126	-100.00%	-	Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY	-	-	-	-701	-100.00%	-	Jun 30, 2024
RUSSELL INVESTMENTS GROUP, LTD.	-	-	-	-7	-100.00%	-	Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC	-	-	-	-2	-100.00%	-	Jun 30, 2024

Aerovate Therapeutics's largest sold out institutional shareholder by shares sold is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., sold -1.20M shares, valued at -, as of undefined.

Aerovate Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY ADVISOR SERIES VII	0.03%	224,000	-24,700	-9.93%	Jan 31, 2024
ALGER FUNDS	0.03%	24,747	-	-	Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS	0.02%	8,963	-	-	Mar 31, 2024
FIDELITY SECURITIES FUND	0.00%	459,949	-	-	Jan 31, 2024
FIDELITY SELECT PORTFOLIOS	0.00%	311,676	-	-	Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC	0.00%	19,839	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.00%	1,574	-	-	Mar 31, 2024
DRIEHAUS MUTUAL FUNDS	0.00%	20,601	560	2.79%	Mar 28, 2024
ALPS ETF Trust	0.00%	20,240	712	3.65%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	553,504	-142,663	-20.49%	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	29,542	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	132,877	4,232	3.29%	Feb 29, 2024
Principal Exchange-Traded Funds	0.00%	3,989	-327	-7.58%	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	772	-	-	Mar 31, 2024
FIDELITY COVINGTON TRUST	0.00%	4,441	-	-	Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	7,004	-669	-8.72%	Mar 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	62,720	-	-	Jan 31, 2024
Brinker Capital Destinations Trust	0.00%	10,721	-9,218	-46.23%	Feb 29, 2024
RBB FUND, INC.	0.00%	11,565	-	-	Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	3,689	-969	-20.80%	Mar 31, 2024
VANGUARD WORLD FUND	0.00%	28,272	-4,724	-14.32%	Feb 29, 2024
Global X Funds	0.00%	4,920	-	-	Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC	0.00%	529	68	14.75%	Mar 31, 2024
MUTUAL FUND SERIES TRUST	0.00%	445,500	433,322	3558.24%	Mar 31, 2024
TIAA-CREF LIFE FUNDS	0.00%	190	-	-	Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	798	58	7.84%	Mar 31, 2024
AMERICAN CENTURY ETF TRUST	0.00%	7,175	5,264	275.46%	Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	3,616	-	-	Mar 31, 2024
T. Rowe Price Index Trust, Inc.	0.00%	719	70	10.79%	Mar 31, 2024
NORTHERN FUNDS	0.00%	4,547	8	0.18%	Mar 28, 2024
CLEARWATER INVESTMENT TRUST	0.00%	268	268	-	Mar 28, 2024
EQ ADVISORS TRUST	0.00%	31,191	-67	-0.21%	Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	51,268	6,406	14.28%	Feb 29, 2024
iSHARES TRUST	0.00%	404,702	-23,233	-5.43%	Mar 31, 2024
RYDEX SERIES FUNDS	0.00%	91	-	-	Dec 31, 2023
VALIC Co I	0.00%	4,290	-17	-0.39%	Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	1,797	-	-	Mar 31, 2024
TIAA-CREF FUNDS	0.00%	39,055	2,935	8.13%	Jan 31, 2024
RYDEX DYNAMIC FUNDS	0.00%	46	-	-	Dec 31, 2023
Guggenheim Active Allocation Fund	0.00%	63	-	-	Feb 29, 2024
PENN SERIES FUNDS INC	0.00%	300	-	-	Mar 28, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,281	397	21.07%	Jan 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	1,102	198	21.90%	Jan 31, 2024
ProFunds	0.00%	86	-9	-9.47%	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	6,658	3,329	100.00%	Jan 31, 2024
PROSHARES TRUST	0.00%	1,639	197	13.66%	Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	643	322	100.31%	Feb 29, 2024
RYDEX VARIABLE TRUST	0.00%	6	-	-	Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	9,600	-	-	Mar 31, 2024
Brighthouse Funds Trust II	0.00%	3,363	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	1,266	-6	-0.47%	Jan 31, 2024
ETF Series Solutions	0.00%	58	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	1,049	-1,371	-56.65%	Jan 31, 2024
ALLSPRING MASTER TRUST	0.00%	144	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	4,607	68	1.50%	Mar 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	5,522	660	13.57%	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	4,273	1,134	36.13%	Mar 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	1,056	-	-	Dec 31, 2023
Advisors' Inner Circle Fund III	0.00%	53	13	32.50%	Jan 31, 2024
Bridge Builder Trust	0.00%	2,101	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	1,493	-100	-6.28%	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	1,604	414	34.79%	Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	258	-	-	Mar 31, 2024
BLACKROCK FUNDS	0.00%	1,259	-	-	Jan 31, 2024

Aerovate Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 224.00K shares, compromising 0.03% of its total assets.

Aerovate Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	93	17.72%
31 Mar, 24	79	25.40%
31 Dec, 23	63	8.62%
30 Sep, 23	58	-3.33%
30 Jun, 23	60	-7.69%
31 Mar, 23	65	-5.80%
31 Dec, 22	69	27.78%
30 Sep, 22	54	10.20%
30 Jun, 22	49	8.89%
31 Mar, 22	45	-4.26%
31 Dec, 21	47	14.63%
30 Sep, 21	41	127.78%
30 Jun, 21	18	-

As of 30 Jun 24, 93 institutions are holding Aerovate Therapeutics's shares, representing an increase of 17.72% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	27,181,983	-4.43%
31 Mar, 24	28,443,127	0.96%
31 Dec, 23	28,171,582	-1.03%
30 Sep, 23	28,465,427	-0.03%
30 Jun, 23	28,473,066	9.58%
31 Mar, 23	25,984,835	-5.18%
31 Dec, 22	27,404,541	1.56%
30 Sep, 22	26,982,707	4.67%
30 Jun, 22	25,779,642	-0.63%
31 Mar, 22	25,942,328	1.40%
31 Dec, 21	25,584,878	18.15%
30 Sep, 21	21,654,819	8.46%
30 Jun, 21	19,965,342	-

Aerovate Therapeutics (AVTE) has 27.18M shares outstanding as of 30 Jun 24, down -4.43% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	97.79%	0.93%
31 Mar, 24	102.33%	0.89%
31 Dec, 23	106.99%	1.01%
30 Sep, 23	102.98%	0.80%
30 Jun, 23	113.14%	1.03%
31 Mar, 23	104.87%	0.84%
31 Dec, 22	111.98%	0.92%
30 Sep, 22	110.34%	0.99%
30 Jun, 22	105.61%	0.94%
31 Mar, 22	106.28%	0.93%
31 Dec, 21	107.12%	1.30%
30 Sep, 21	90.66%	1.06%
30 Jun, 21	92.54%	-

As of 30 Jun 24, Aerovate Therapeutics is held by 97.79% institutional shareholders, representing a 0.93% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	62	55.00%
31 Mar, 24	40	29.03%
31 Dec, 23	31	29.17%
30 Sep, 23	24	-11.11%
30 Jun, 23	27	-6.90%
31 Mar, 23	29	-27.50%
31 Dec, 22	40	33.33%
30 Sep, 22	30	100.00%
30 Jun, 22	15	-37.50%
31 Mar, 22	24	-14.29%
31 Dec, 21	28	-12.50%
30 Sep, 21	32	77.78%
30 Jun, 21	18	-

62 institutional shareholders have increased their position in AVTE stock as of 30 Jun 24 compared to 40 in the previous quarter (a 55.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	14	-39.13%
31 Mar, 24	23	35.29%
31 Dec, 23	17	41.67%
30 Sep, 23	12	-7.69%
30 Jun, 23	13	-48.00%
31 Mar, 23	25	13.64%
31 Dec, 22	22	37.50%
30 Sep, 22	16	-36.00%
30 Jun, 22	25	108.33%
31 Mar, 22	12	33.33%
31 Dec, 21	9	125.00%
30 Sep, 21	4	-
30 Jun, 21	-	-

14 institutional shareholders have reduced their position in AVTE stock as of 30 Jun 24 compared to 23 in the previous quarter (a -39.13% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	93	17.72%	27,181,983	-4.43%	97.79%	0.93%	62	55.00%	14	-39.13%
31 Mar, 24	79	25.40%	28,443,127	0.96%	102.33%	0.89%	40	29.03%	23	35.29%
31 Dec, 23	63	8.62%	28,171,582	-1.03%	106.99%	1.01%	31	29.17%	17	41.67%
30 Sep, 23	58	-3.33%	28,465,427	-0.03%	102.98%	0.80%	24	-11.11%	12	-7.69%
30 Jun, 23	60	-7.69%	28,473,066	9.58%	113.14%	1.03%	27	-6.90%	13	-48.00%
31 Mar, 23	65	-5.80%	25,984,835	-5.18%	104.87%	0.84%	29	-27.50%	25	13.64%
31 Dec, 22	69	27.78%	27,404,541	1.56%	111.98%	0.92%	40	33.33%	22	37.50%
30 Sep, 22	54	10.20%	26,982,707	4.67%	110.34%	0.99%	30	100.00%	16	-36.00%
30 Jun, 22	49	8.89%	25,779,642	-0.63%	105.61%	0.94%	15	-37.50%	25	108.33%
31 Mar, 22	45	-4.26%	25,942,328	1.40%	106.28%	0.93%	24	-14.29%	12	33.33%
31 Dec, 21	47	14.63%	25,584,878	18.15%	107.12%	1.30%	28	-12.50%	9	125.00%
30 Sep, 21	41	127.78%	21,654,819	8.46%	90.66%	1.06%	32	77.78%	4	-
30 Jun, 21	18	-	19,965,342	-	92.54%	-	18	-	-	-

Aerovate Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 20, 2024	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner		P-Purchase	Buy	928,110	$1.67	$1.55M	7,893,678
Jun 14, 2024	Eldridge George A	officer	SEE REMARKS	S-Sale	Sell	15,000	$25.03	$375.45K	5,022
Jun 14, 2024	Verwijs Marinus	officer	CHIEF TECHNICAL OFFICER	S-Sale	Sell	10,600	$25.00	$265.00K	-
Jun 14, 2024	Gillies Hunter	officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	6,000	$24.50	$147.00K	5,602

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jun 20, 2024	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner		P-Purchase	Buy	928,110	$1.67	$1.55M	7,893,678

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 02, 2024	Dake Benjamin T	officer	SEE REMARKS	M-Exempt	Sell	10,548	$1.74	$18.35K	1,507
Aug 02, 2024	Dake Benjamin T	officer	SEE REMARKS	M-Exempt	Sell	1,507	$1.74	$2.62K	-
Jun 14, 2024	Eldridge George A	officer	SEE REMARKS	M-Exempt	Sell	15,000	$2.14	$32.10K	28,763
Jun 14, 2024	Eldridge George A	officer	SEE REMARKS	S-Sale	Sell	15,000	$25.03	$375.45K	5,022
Jun 14, 2024	Verwijs Marinus	officer	CHIEF TECHNICAL OFFICER	M-Exempt	Sell	10,600	$14.59	$154.65K	68,800
Jun 14, 2024	Verwijs Marinus	officer	CHIEF TECHNICAL OFFICER	S-Sale	Sell	10,600	$25.00	$265.00K	-
Jun 14, 2024	Gillies Hunter	officer	CHIEF MEDICAL OFFICER	M-Exempt	Sell	6,000	$2.14	$12.84K	83,510
Jun 14, 2024	Gillies Hunter	officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	6,000	$24.50	$147.00K	5,602

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 02, 2024	Dake Benjamin T	officer	SEE REMARKS	M-Exempt	Buy	1,507	$1.74	$2.62K	14,252
Aug 02, 2024	Dake Benjamin T	officer	SEE REMARKS	M-Exempt	Buy	11,454	$1.74	$19.93K	12,745
Aug 02, 2024	Dake Benjamin T	officer	SEE REMARKS	M-Exempt	Sell	10,548	$1.74	$18.35K	1,507
Aug 02, 2024	Dake Benjamin T	officer	SEE REMARKS	M-Exempt	Sell	1,507	$1.74	$2.62K	-
Jun 20, 2024	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner		P-Purchase	Buy	928,110	$1.67	$1.55M	7,893,678
Jun 14, 2024	Eldridge George A	officer	SEE REMARKS	M-Exempt	Sell	15,000	$2.14	$32.10K	28,763
Jun 14, 2024	Eldridge George A	officer	SEE REMARKS	M-Exempt	Buy	15,000	$2.14	$32.10K	20,022
Jun 14, 2024	Eldridge George A	officer	SEE REMARKS	S-Sale	Sell	15,000	$25.03	$375.45K	5,022
Jun 14, 2024	Verwijs Marinus	officer	CHIEF TECHNICAL OFFICER	M-Exempt	Sell	10,600	$14.59	$154.65K	68,800
Jun 14, 2024	Verwijs Marinus	officer	CHIEF TECHNICAL OFFICER	M-Exempt	Buy	10,600	$14.59	$154.65K	10,600
Jun 14, 2024	Verwijs Marinus	officer	CHIEF TECHNICAL OFFICER	S-Sale	Sell	10,600	$25.00	$265.00K	-
Jun 14, 2024	Gillies Hunter	officer	CHIEF MEDICAL OFFICER	M-Exempt	Sell	6,000	$2.14	$12.84K	83,510
Jun 14, 2024	Gillies Hunter	officer	CHIEF MEDICAL OFFICER	M-Exempt	Buy	6,000	$2.14	$12.84K	11,602
Jun 14, 2024	Gillies Hunter	officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	6,000	$24.50	$147.00K	5,602
Jun 07, 2024	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner		A-Award	Buy	12,500	$18.90	$236.25K	12,500
Jun 07, 2024	Santel Donald J	director	-	A-Award	Buy	12,500	$18.90	$236.25K	12,500
Jun 07, 2024	Resnick Joshua	director	-	A-Award	Buy	12,500	$18.90	$236.25K	12,500
Jun 07, 2024	Katabi Maha	director, 10 percent owner		A-Award	Buy	12,500	$18.90	$236.25K	12,500
Jun 07, 2024	Iwicki Mark T	director	-	A-Award	Buy	12,500	$18.90	$236.25K	12,500
Jun 07, 2024	GRAYZEL DAVID S.	director	-	A-Award	Buy	12,500	$18.90	$236.25K	12,500

The last insider sell of Aerovate Therapeutics's stock was made by Dake Benjamin T on Aug 02 2024, selling 10,548 shares at $1.74 per share (valued at $18.35K). The last insider buy of AVTE was made by RA CAPITAL MANAGEMENT, L.P. on Jun 20 2024, buying 928,110 shares at $1.67 per share (worth $1.55M).

Aerovate Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	2	2	100.00%
Q2 2024	23	44	52.27%
Q1 2024	33	53	62.26%
Q4 2023	15	44	34.09%
Q3 2023	13	31	41.94%
Q2 2023	24	50	48.00%
Q1 2023	25	54	46.30%
Q4 2022	34	97	35.05%
Q3 2022	4	21	19.05%
Q2 2022	10	1	1000.00%
Q1 2022	3	-	-
Q4 2021	5	-	-
Q3 2021	17	7	242.86%
Q2 2021	23	12	191.67%
Q1 2021	2	-	-

2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Aerovate Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	1	29	3.45%
Q1 2024	-	23	-
Q4 2023	-	12	-
Q3 2023	-	10	-
Q2 2023	-	18	-
Q1 2023	-	20	-
Q4 2022	-	46	-
Q3 2022	-	5	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	6	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Aerovate Therapeutics's stocks.

Aerovate Therapeutics Peer Ownership

Ticker	Company
MLYS	Mineralys Therapeutics, Inc.
ACRV	Acrivon Therapeutics, Inc. Common Stock
ANTX	AN2 Therapeutics, Inc.
RZLT	Rezolute, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
ADAG	Adagene Inc.
OPT	Opthea Limited

AVTE Ownership FAQ

Who Owns Aerovate Therapeutics?

Aerovate Therapeutics is owned by institutional shareholders (97.79%), insiders (0.02%), and public (2.19%). The largest institutional shareholder of Aerovate Therapeutics is RA CAPITAL MANAGEMENT, L.P. (33.07% of total shares) and the top mutual fund owner is FIDELITY ADVISOR SERIES VII (0.03% of total shares).

Who are the major institutional shareholders of Aerovate Therapeutics?

Aerovate Therapeutics's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., SOFINNOVA INVESTMENTS, INC., TCG CROSSOVER MANAGEMENT, LLC, ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). The top five shareholders own together 66.21% of the company's share outstanding.

How many Aerovate Therapeutics shareholders are there?

As of Jun 2024, there are 93 institutional shareholders of Aerovate Therapeutics.

What percentage of Aerovate Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?

RA CAPITAL MANAGEMENT, L.P owns 9.19M shares of Aerovate Therapeutics, representing 33.07% of the company's total shares outstanding, valued at $15.26M (as of Jun 2024).

What percentage of Aerovate Therapeutics is owned by SOFINNOVA INVESTMENTS, INC?

As of Jun 2024, SOFINNOVA INVESTMENTS, INC holds 3.76M shares of Aerovate Therapeutics (AVTE), compromising 13.52% of the company, valued at $6.24M.

What percentage of Aerovate Therapeutics is owned by TCG CROSSOVER MANAGEMENT, LLC?

TCG CROSSOVER MANAGEMENT, LLC is the third largest holder of Aerovate Therapeutics. The company owns 2.24M of the company's shares outstanding (worth $3.72M).